Background and goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...

EQT Life Sciences is pleased to announce that the LSP 7 Fund has invested in Kinaset Therapeutics (the "Company"), a clinical-stage biopharmaceutical company based in Boston, U.S. developing a novel ...

Background and Goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...

Twister is Aptar Pharma's new dry powder inhaler--courtesy Aptar Pharma Just in time for World Asthma Day, Aptar Pharma ($ATR) is launching a capsule-based dry powder ...

Dry Powder Inhalers (DPIs) are employed to supply a safe dose of Active Pharmaceutical Ingredient (API) to the deep lung. Image Credit: Freeman Technology An excipient transports the delicate ...

Kumar was in Chennai on Thursday to announce opening of regional reference laboratory in the city. Global pharma major Lupin Limited on Thursday announced the launch of Tiotropium Bromide Inhalation ...

Pharma major Ranbaxy Laboratories Ltd Tuesday launched its branded inhalation capsules in India for the treatment of asthma. A unique combination of long acting Beta2-agonist Formoterol and the most ...

NEW YORK & DUBLIN--(BUSINESS WIRE)--Feb. 24, 2012-- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that it has been granted European ...

Lupin Limited announced that the United States Food and Drug Administration (USFDA) has granted approval for its Abbreviated New Drug Application for Tiotropium Bromide Inhalation Powder, 18 ...